Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05613816
Other study ID # MT_Asensus_Register
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 22, 2022
Est. completion date November 2024

Study information

Verified date February 2024
Source University Hospital Tuebingen
Contact Jürgen Andress, Dr
Phone 07071 29-82211
Email Juergen.andress@med.uni-tuebingen.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a prospective, single-center, observational clinical trial at the Department of Women's Health of the University Hospital Tübingen.


Description:

This is a prospective, single-center, observational clinical trial at the Department of Women's Health of the University Hospital Tübingen. 100 patients affected by uterine diseases with indication for hysterectomy undergo treatment with robotically assisted laparoscopic procedures using the Senhance Surgical System (See Synopsis - Indication A) and are compared to a cohort of 200 patients treated with conventional laparoscopic surgery from a similar ongoing study (Ethics vote: 621 /2018BO1). 100 patients affected by other uterine conditions / adnexal conditions that require uterine/adnexal/tubal surgery (see Synopsis - Indication B) undergo treatment with robotically assisted laparoscopic procedures using the Senhance Surgical System and are compared to a cohort of 200 patients with indication for other uterine conditions / adnexal conditions that require uterine/adnexal/tubal surgery (see Synopsis - Indication B) who underwent conventional laparoscopic surgery at the Department of Women's Health in the past. At the end of patient recruitment, surgical procedure times, estimated blood loss, intra- and post-operative complications and the percentage of conversions from the robotic assisted treatment/conventional laparoscopic surgery to multiple access and/or to a laparotomic (open) approach will be documented. Patients will answer questionnaires (German version of the Short Form-36health survey questionnaire (Medical Outcomes Trust), German version of the female sexual function index (FSFI)) at baseline and at 3 and 6 months of follow-up. A questionnaire for patient satisfaction will be answered one day post procedural, at discharge and at 3 and 6 months follow-up.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date November 2024
Est. primary completion date November 2024
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - age =18 years - BMI =40 kg/m2 - indication for hysterectomy for benign disease or prophylactic surgery due to hereditary cancer - indication for radical hysterectomy and/or pelvic-/para-aortic (sentinel-node) lymphadenectomy for cervical cancer - indication for modified radical hysterectomy and/or pelvic-/para-aortic (sentinel-node) lymphadenectomy for endometrial cancer - indication for other uterine conditions / adnexal conditions that require uterine/adnexal/tubal surgery: Fibroids, Endometriomas, Cystic masses, Ectopic pregnancies, Sactosalpinx, Inflammatory adnexal disease, Opportunistic salpingectomy as part of hysterectomy or exclusively, Cervico-/Sacrokolpopexy - size of uterus and vagina allows for retrieval by the vaginal route in cancer patients - written informed consent Exclusion Criteria: - known extensive intra-abdominal adhesions - anaesthesiological contraindications to laparoscopy - women with pacemaker or other implants where electrosurgery is to be avoided - women with known defects of the hemostasis - pregnancy - other internal or anatomical criteria that preclude a minimal invasive approach - inability to understand patient information

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Senhance Surgical System
100 patients affected by uterine diseases with indication for hysterectomy undergo treatment with robotically assisted laparoscopic procedures using the Senhance Surgical System

Locations

Country Name City State
Germany University Hospital Tuebingen, Department of Women's Health Tübingen

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Tuebingen

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary operating time time from first incision to skin closure 60 minutes
Secondary time under narcosis duration of time in which the study participant is under the influence of a narcotic substance 60 minutes
Secondary console time duration of time during which a surgeon is controlling the surgical robot from a console 60 minutes
Secondary estimated blood loss (milliliters) using the following formula: ((Hemoglobin concentration preoperative (g/l)) - (Hemoglobin 1st day postoperative (g/l)))/((Hemoglobin preoperative (g/l)) - (Hemoglobin 1st day postoperative (g/l)))/2) × 1000 60 minutes
Secondary conversion to other surgical procedures (e. g. open) if the original surgical plan during surgery is altered and switched to a different type of surgery to address unforeseen complications or difficulties that arise during the operation 60 minutes
Secondary time to discharge length of time that a patient spends in the hospital before they are well enough to be released and sent home 60 minutes
Secondary intraoperative complications (occurring during the surgical procedure) 60 minutes
Secondary perioperative complications (occurring less than 24h after the surgical procedure) 24 hours
Secondary postoperative complications (occurring more than 24h after the surgical procedure up to 6 months after surgical procedure) 6 months
Secondary German version of the Short Form-36health survey questionnaire (Medical Outcomes Trust) The SF-36 questionnaire (Short Form 36 Health Survey) is a widely used measure of health status and quality of life. The questionnaire consists of 36 items that measure eight health domains: physical functioning, role limitations due to physical health, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. The scores range from 0 to 100 for each domain, with higher scores indicating better health status. Therefore, higher scores on the SF-36 indicate a better outcome. at baseline, and at 3 and 6 months of follow-up
Secondary German version of the female sexual function index (FSFI) questionnaire female sexual function index: a multidimensional self-report instrument for the assessment of female sexual function; The total composite sexual function score is a sum of domain scores and ranges from 2.0 (not sexually active and no desire) to 36.0. Higher scores on the FSFI indicate better sexual function. at baseline, and at 3 and 6 months of follow-up
Secondary Questionnaire for patient satisfaction Including A Pain Score ( No Pain 0 - Worst Possible Pain 10) and B Satisfaction with: the severity of the pain; the quality of recovery; the scars; the surgery overall (Scale satisfaction: Extremely dissatisfied -- Dissatisfied -- Somewhat dissatisfied -- Neither satisfied nor dissatisfied -- Somewhat satisfied -- Satisfied -- Extremely satisfied) at one day post procedural, at discharge and at 3 and 6 months follow-up
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02868437 - Effectiveness of Hyaluronic Acid Gel in the Prevention of Intrauterine Adhesions After Second Trimester Abortion Phase 4
Completed NCT00341458 - Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics
Completed NCT03093675 - Robotic Assisted Surgery for Treatment of Gynecological Diseases: Pilot Study N/A
Recruiting NCT05823935 - Laparoscopic Versus Vaginal Cuff Closure During LH in Benign Gynecological Lesions N/A
Completed NCT04679675 - Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial N/A
Completed NCT04436354 - The Effect of Trendelenburg Lithotomy Position on Pain and Procedural Time During Vaginoscopic Office Hysteroscopy N/A
Terminated NCT03827824 - Virtual Reality on Perception of Pain and Anxiety by Hysteroscopy N/A
Completed NCT03861195 - Comparative Prospective Data Collection in Connection With Two Different Treatment Methods: Robotic Assisted Laparoscopy and Conventional Laparoscopy
Completed NCT00793260 - Deep Dive Randomized Control Trial N/A
Completed NCT04808583 - Uterine Artery Ligation at Origin in Total Laparscopic Hystrectomy N/A
Withdrawn NCT04184323 - SIRT-1 Antagonism for Endometrial Receptivity Phase 2
Completed NCT04571671 - Do müllerian Anomalies Affect Embryo Implantation?
Completed NCT00000612 - Soy Estrogen Alternative Study (SEA) Phase 2
Active, not recruiting NCT05453006 - HPV Self-Sampling in Somali Women N/A
Completed NCT02631837 - Hysterectomy by Transabdominal Laparoscopy or NOTES N/A
Recruiting NCT05533710 - Comparison Between Erector Spinae Plane Block and Transversus Abdominis Plane Block on Postoperative Analgesia After Total Abdominal Hysterectomy N/A
Recruiting NCT04061967 - SMS-based Summons in Cervical Screening N/A
Not yet recruiting NCT02682433 - 3D Sonohysterography vs Hysteroscopy: Study for the Evaluation of Intrauterine Abnormalities Phase 3
Recruiting NCT06019039 - Power Doppler Ultrasonography in Localization of Epidural Catheter